Pharmaceutical company Simtra BioPharma Solutions has bought a 65-acre property from Cook Group, including a 300,000 square-foot facility, to expand its Bloomington operations, potentially to manufacture cancer drugs.
The company bought the property at 301 N. Curry, which is on Bloomington's northwest side. The site is east of Profile Parkway and the Ivy Tech and Cook Medical campuses. Cook, a local medical device maker, had bought the former General Electric property in 2017 for $6.5 million.
Rhonda Luniak, director of communications for Simtra BioPharma Solutions, said via email that the companies were not disclosing financial specifics about the deal at this time. Local property records show the Curry Pike property most recently had an assessed value of $10.7 million.
Simtra primarily operates high-tech machines that fill syringes with medications to treat chronic conditions such as diabetes and life-threatening illnesses such as cancer.
“The addition of this site provides Simtra significant flexibility to rapidly expand its manufacturing footprint in the United States to respond to growing capacity demands from both new and existing customers,” the company said in a news release.
© 2025 HeraldTimesOnline, Bloomington, IN